View in EDS

915MO Long-term outcomes from KEYNOTE-048: Pembrolizumab (pembro) alone or with chemotherapy (pembro+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Saved in:
Bibliographic Details
Title: 915MO Long-term outcomes from KEYNOTE-048: Pembrolizumab (pembro) alone or with chemotherapy (pembro+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Authors: Greil, R.1 (AUTHOR), Rischin, D.2 (AUTHOR), Harrington, K.J.3 (AUTHOR), Soulières, D.4 (AUTHOR), Tahara, M.5 (AUTHOR), de Castro, G.6 (AUTHOR), Psyrri, A.7 (AUTHOR), Baste, N.8 (AUTHOR), Neupane, P.9 (AUTHOR), Bratland, Å.10 (AUTHOR), Fuereder, T.11 (AUTHOR), Hughes, B.G.M.12 (AUTHOR), Mesia, R.13 (AUTHOR), Ngamphaiboon, N.14 (AUTHOR), Rordorf, T.15 (AUTHOR), Ishak, W.Z. Wan16 (AUTHOR), Lin, J.17 (AUTHOR), Swaby, R.F.17 (AUTHOR), Gumuscu, B.17 (AUTHOR), Burtness, B.18 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS660-S661. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152695565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 915MO Long-term outcomes from KEYNOTE-048: Pembrolizumab (pembro) alone or with chemotherapy (pembro+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Greil%2C+R%2E%22">Greil, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rischin%2C+D%2E%22">Rischin, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harrington%2C+K%2EJ%2E%22">Harrington, K.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Soulières%2C+D%2E%22">Soulières, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tahara%2C+M%2E%22">Tahara, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Castro%2C+G%2E%22">de Castro, G.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Psyrri%2C+A%2E%22">Psyrri, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baste%2C+N%2E%22">Baste, N.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Neupane%2C+P%2E%22">Neupane, P.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bratland%2C+Å%2E%22">Bratland, Å.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fuereder%2C+T%2E%22">Fuereder, T.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hughes%2C+B%2EG%2EM%2E%22">Hughes, B.G.M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mesia%2C+R%2E%22">Mesia, R.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ngamphaiboon%2C+N%2E%22">Ngamphaiboon, N.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rordorf%2C+T%2E%22">Rordorf, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ishak%2C+W%2EZ%2E+Wan%22">Ishak, W.Z. Wan</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+J%2E%22">Lin, J.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Swaby%2C+R%2EF%2E%22">Swaby, R.F.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gumuscu%2C+B%2E%22">Gumuscu, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burtness%2C+B%2E%22">Burtness, B.</searchLink><relatesTo>18</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS660-S661. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.08.1030
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S660
    Titles:
      – TitleFull: 915MO Long-term outcomes from KEYNOTE-048: Pembrolizumab (pembro) alone or with chemotherapy (pembro+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Greil, R.
      – PersonEntity:
          Name:
            NameFull: Rischin, D.
      – PersonEntity:
          Name:
            NameFull: Harrington, K.J.
      – PersonEntity:
          Name:
            NameFull: Soulières, D.
      – PersonEntity:
          Name:
            NameFull: Tahara, M.
      – PersonEntity:
          Name:
            NameFull: de Castro, G.
      – PersonEntity:
          Name:
            NameFull: Psyrri, A.
      – PersonEntity:
          Name:
            NameFull: Baste, N.
      – PersonEntity:
          Name:
            NameFull: Neupane, P.
      – PersonEntity:
          Name:
            NameFull: Bratland, Å.
      – PersonEntity:
          Name:
            NameFull: Fuereder, T.
      – PersonEntity:
          Name:
            NameFull: Hughes, B.G.M.
      – PersonEntity:
          Name:
            NameFull: Mesia, R.
      – PersonEntity:
          Name:
            NameFull: Ngamphaiboon, N.
      – PersonEntity:
          Name:
            NameFull: Rordorf, T.
      – PersonEntity:
          Name:
            NameFull: Ishak, W.Z. Wan
      – PersonEntity:
          Name:
            NameFull: Lin, J.
      – PersonEntity:
          Name:
            NameFull: Swaby, R.F.
      – PersonEntity:
          Name:
            NameFull: Gumuscu, B.
      – PersonEntity:
          Name:
            NameFull: Burtness, B.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2020 Supplement 4
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1